Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;46(6):1086-1088.
doi: 10.1111/ced.14711. Epub 2021 Jun 4.

Who writes dermatology randomized controlled trials? The need to specify the role of medical writers

L Steele  1   2 , H L Lee  2 , E Earp  3 , A Hong  2 , J Thomson  1   2
Affiliations

Who writes dermatology randomized controlled trials? The need to specify the role of medical writers

L Steele et al. Clin Exp Dermatol. 2021 Aug.

Abstract

Medical writers may make major contributions to the preparation of a manuscript, but are not listed as authors. We assessed the prevalence, affiliation and role of medical writers in dermatology randomized controlled trials (RCTs) published in 2019 in the top 7 medical and top 10 dermatology journals. Medical writers were identified in 39/83 trials (47%), all of which were exclusively industry-funded trials (39/47, prevalence 83%). Most studies stated their role as 'medical writing support' and/or 'editorial assistance' (35/39, 90%), but when more information was provided, four studies specified first draft preparation (50% of RCTs in general medical and 1.3% of RCTs in dermatology journals). Medical writers are common in dermatology trials but their role is often vaguely stated. In April 2020 the British Journal or Dermatology and Clinical and Experimental Dermatology adopted CRediT (Contributor Roles Taxonomy), which describes contributions of authors and may help clarify who writes trial manuscripts.

PubMed Disclaimer

References

    1. Larkin M. Whose article is it anyway? Lancet 1999; 354: 136.
    1. Brennan TA. Buying editorials. N Engl J Med 1994; 331: 673-5. discussion 676.
    1. McHenry L. Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine. Mens Sana Monogr 2010; 8: 129-45.
    1. Meffert JJ. Key opinion leaders: where they come from and how that affects the drugs you prescribe. Dermatol Ther 2009; 22: 262-8.
    1. Steele L, Earp E, Hong A. How prevalent are financial conflicts of interest in dermatology randomized controlled trials? Clin Exp Dermatol 2021; 46: 715-19.

LinkOut - more resources